478 related articles for article (PubMed ID: 30662405)
1. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
[TBL] [Abstract][Full Text] [Related]
2. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, function, and regulation of sterol and nonsterol isoprenoids.
Faulkner R; Jo Y
Front Mol Biosci; 2022; 9():1006822. PubMed ID: 36275615
[TBL] [Abstract][Full Text] [Related]
4. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
5. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
6. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.
Elson CE; Peffley DM; Hentosh P; Mo H
Proc Soc Exp Biol Med; 1999 Sep; 221(4):294-311. PubMed ID: 10460692
[TBL] [Abstract][Full Text] [Related]
7. Mevalonate-suppressive dietary isoprenoids for bone health.
Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing.
Chen L; Ma MY; Sun M; Jiang LY; Zhao XT; Fang XX; Man Lam S; Shui GH; Luo J; Shi XJ; Song BL
J Lipid Res; 2019 Oct; 60(10):1765-1775. PubMed ID: 31455613
[TBL] [Abstract][Full Text] [Related]
9. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells.
Göbel A; Breining D; Rauner M; Hofbauer LC; Rachner TD
Cell Death Dis; 2019 Jan; 10(2):91. PubMed ID: 30692522
[TBL] [Abstract][Full Text] [Related]
10. Post-Translational Regulation of HMG CoA Reductase.
Jo Y; DeBose-Boyd RA
Cold Spring Harb Perspect Biol; 2022 Dec; 14(12):. PubMed ID: 35940903
[TBL] [Abstract][Full Text] [Related]
11. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo.
Broitman SA; Wilkinson J; Cerda S; Branch SK
Adv Exp Med Biol; 1996; 401():111-30. PubMed ID: 8886130
[TBL] [Abstract][Full Text] [Related]
12. Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase.
De Giorgi M; Jarrett KE; Burton JC; Doerfler AM; Hurley A; Li A; Hsu RH; Furgurson M; Patel KR; Han J; Borchers CH; Lagor WR
J Lipid Res; 2020 Dec; 61(12):1675-1686. PubMed ID: 33109681
[TBL] [Abstract][Full Text] [Related]
13. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
14. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
Duncan RE; Lau D; El-Sohemy A; Archer MC
Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
[TBL] [Abstract][Full Text] [Related]
15. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
[TBL] [Abstract][Full Text] [Related]
16. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells.
Yeganehjoo H; DeBose-Boyd R; McFarlin BK; Mo H
Nutr Cancer; 2017; 69(4):682-691. PubMed ID: 28362175
[TBL] [Abstract][Full Text] [Related]
18. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo.
He L; Mo H; Hadisusilo S; Qureshi AA; Elson CE
J Nutr; 1997 May; 127(5):668-74. PubMed ID: 9164984
[TBL] [Abstract][Full Text] [Related]
19. Potential of tocotrienols in the prevention and therapy of Alzheimer's disease.
Xia W; Mo H
J Nutr Biochem; 2016 May; 31():1-9. PubMed ID: 27133418
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.
Afshordel S; Kern B; Clasohm J; König H; Priester M; Weissenberger J; Kögel D; Eckert GP
Pharmacol Res; 2015 Jan; 91():69-77. PubMed ID: 25497898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
